Ricky is the Chairman and CEO of PHASE Scientific, as well as the lead inventor of the company’s core technology. Ricky has been selected as one of the recipients of the Ten Outstanding Young Persons of the World, the Ten Outstanding of Young Persons in Hong Kong, the InnoStars Awards, the Young Industrialist of Hong Kong Awards and the HKSAR Chief Executive's Commendation for Community Service for his outstanding achievements in biotechnology innovations and his notable contributions to the fight against COVID-19 pandemic.

Ricky made significant breakthroughs in liquid biopsy and rapid point-of-care testing using the proprietary sample preparation technology he developed. With 55 patents granted, the technology provides an innovative solution to the problem of low-concentration target molecule detection. The technology improves the performance of diagnostic testing, making it faster, more accurate and cost-effective.

Ricky is among the few who have received recognition in both the West and the East. From receiving research funding from world-renowned entities and FDA approval to his high-efficiency COVID-19 RNA extraction technology being designated as a “Major Technology” by the Ministry of Science and Technology of China. Ricky is currently engaged in research and product development for the detection of cancer and infectious diseases.